2851 - 2875 of 8620 Results
Title
Year
-
OPENTitle: Use of Florbetapir-PET for Imaging β-Amyloid PathologyJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 305Issue #: 3Start Page: 275End Page: 275Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jama.2010.2008Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7041965Citation Count: 1029
- Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons2017OPENTitle: Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal PersonsJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 317Issue #: 22Start Page: 2305End Page: 2305Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jama.2017.6669Best OA location URL: https://jamanetwork.com/journals/jama/articlepdf/2631529/jama_donohue_2017_oi_170051.pdfCitation Count: 399
- Measuring the Lifespace of People With Parkinson’s Disease Using Smartphones: Proof of Principle2014OPENTitle: Measuring the Lifespace of People With Parkinson’s Disease Using Smartphones: Proof of PrincipleJournal Name: JMIR mhealth and uhealthPublisher: JMIR Publications Inc.Vol: 2Issue #: 1Start Page: e13End Page: e13Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.2196/mhealth.2799Best OA location URL: https://mhealth.jmir.org/2014/1/e13/PDFCitation Count: 85
-
OPENTitle: The natural history of multiple system atrophy: a prospective European cohort studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 12Issue #: 3Start Page: 264End Page: 274Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/s1474-4422(12)70327-7Best OA location URL: http://www.thelancet.com/article/S1474442212703277/pdfCitation Count: 497
- Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study2008OPENTitle: Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 7Issue #: 7Start Page: 583End Page: 590Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/s1474-4422(08)70117-0Best OA location URL: http://www.thelancet.com/article/S1474442208701170/pdfCitation Count: 1461
- Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study2013OPENTitle: Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 12Issue #: 10Start Page: 978End Page: 988Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(13)70210-2Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3879782Citation Count: 261
-
OPENTitle: Hypercholinergic activity in LRRK2 Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 290End Page: 291Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(18)30073-5Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5858987Citation Count: 6
- Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study2013OPENTitle: Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 13Issue #: 2Start Page: 141End Page: 149Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(13)70293-xCitation Count: 663
- Dysregulation of 14‐3‐3 proteins in neurodegenerative diseases with Lewy body or Alzheimer pathology2017OPENTitle: Dysregulation of 14‐3‐3 proteins in neurodegenerative diseases with Lewy body or Alzheimer pathologyJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 4Issue #: 7Start Page: 466End Page: 477Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.421Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.421Citation Count: 37
-
OPENTitle: A Genome‐wide Scan in an Amish Pedigree with ParkinsonismJournal Name: Annals of Human GeneticsPublisher: WileyVol: 72Issue #: 5Start Page: 621End Page: 629Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1469-1809.2008.00452.xBest OA location URL: http://doi.org/10.1111/j.1469-1809.2008.00452.xCitation Count: 12
-
OPENTitle: A Genome‐Wide Linkage Screen in the Amish with Parkinson Disease Points to Chromosome 6Journal Name: Annals of Human GeneticsPublisher: WileyVol: 75Issue #: 3Start Page: 351End Page: 358Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1469-1809.2011.00643.xBest OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1469-1809.2011.00643.xCitation Count: 10
-
OPENTitle: SNCA variants are associated with increased risk for multiple system atrophyJournal Name: Annals of NeurologyPublisher: WileyVol: 65Issue #: 5Start Page: 610End Page: 614Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.21685Citation Count: 273
-
OPENTitle: Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 62Issue #: 2Start Page: 137End Page: 144Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.21157Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2836920Citation Count: 150
- Activation of the mGlu1 metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M4 muscarinic receptor allosteric modulators2018OPENTitle: Activation of the mGlu1 metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M4 muscarinic receptor allosteric modulatorsJournal Name: Molecular PsychiatryPublisher: Springer Science and Business Media LLCVol: 25Issue #: 11Start Page: 2786End Page: 2799Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41380-018-0206-2Best OA location URL: https://www.nature.com/articles/s41380-018-0206-2.pdfCitation Count: 46
- Independent comparison of CogState computerized testing and a standard cognitive battery with neuroimaging2014OPENTitle: Independent comparison of CogState computerized testing and a standard cognitive battery with neuroimagingJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 10Issue #: 6Start Page: 779End Page: 789Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2014.09.001Best OA location URL: http://doi.org/10.1016/j.jalz.2014.09.001Citation Count: 29
- Management of dystonia in Europe: a survey of the European network for the study of the dystonia syndromes2016RESTRICTEDTitle: Management of dystonia in Europe: a survey of the European network for the study of the dystonia syndromesJournal Name: European Journal of NeurologyPublisher: WileyVol: 23Issue #: 4Start Page: 772End Page: 779Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ene.12940Citation Count: 10
-
RESTRICTEDTitle: Higher serum cholesterol and decreased Parkinson's disease risk: A statin‐free cohort studyJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 8Start Page: 1298End Page: 1305Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27413Citation Count: 103
- Differential contribution of Ih to the integration of excitatory synaptic inputs in substantia nigra pars compacta and ventral tegmental area dopaminergic neurons2015RESTRICTEDTitle: Differential contribution of Ih to the integration of excitatory synaptic inputs in substantia nigra pars compacta and ventral tegmental area dopaminergic neuronsJournal Name: European Journal of NeurosciencePublisher: WileyVol: 42Issue #: 9Start Page: 2699End Page: 2706Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ejn.13066Citation Count: 30
-
OPENTitle: Alzheimer Research Forum Live Discussion: Mice on Trial? Issues in the Design of Drug StudiesJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 16Issue #: 1Start Page: 197End Page: 205Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-2009-0961Best OA location URL: https://content.iospress.com:443/download/journal-of-alzheimers-disease/jad00961?id=journal-of-alzheimers-disease%2Fjad00961Citation Count: 1
-
RESTRICTEDTitle: The Linked Clinical Trials initiative (LCT) for Parkinson's diseaseJournal Name: European Journal of NeurosciencePublisher: WileyVol: 49Issue #: 3Start Page: 307End Page: 315Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ejn.14175Citation Count: 19
-
RESTRICTEDTitle: Proteomics of human cerebrospinal fluid – the good, the bad, and the uglyJournal Name: PROTEOMICS – Clinical ApplicationsPublisher: WileyVol: 1Issue #: 8Start Page: 805End Page: 819Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/prca.200700081Citation Count: 57
-
RESTRICTEDTitle: PINK1 p.Leu347Pro mutations in Malays: Prevalence and illustrative casesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 79Issue #:Start Page: 34End Page: 39Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.08.015Citation Count: 21
- Mitochondrial Function in Hereditary Spastic Paraplegia: Deficits in SPG7 but Not SPAST Patient-Derived Stem Cells2020OPENTitle: Mitochondrial Function in Hereditary Spastic Paraplegia: Deficits in SPG7 but Not SPAST Patient-Derived Stem CellsJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00820Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2020.00820/pdfCitation Count: 25
-
RESTRICTEDTitle: Distinct metabolomic signature in cerebrospinal fluid in early parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 10Start Page: 1401End Page: 1408Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27132Best OA location URL: http://orbilu.uni.lu/handle/10993/32300Citation Count: 107
-
OPENTitle: A screening tool to detect clinical manganese neurotoxicityJournal Name: NeuroToxicologyPublisher: Elsevier BVVol: 64Issue #:Start Page: 12End Page: 18Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuro.2017.02.009Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5587364Citation Count: 6